Literature DB >> 28152147

Trend-Based Progression Analysis for Examination of the Topography of Rates of Retinal Nerve Fiber Layer Thinning in Glaucoma.

Chen Lin1, Heather Mak1, Marco Yu2, Christopher Kai-Shun Leung1.   

Abstract

IMPORTANCE: Measurement of the rates of retinal nerve fiber layer (RNFL) thinning has consisted primarily of the circumpapillary RNFL profile. This study reports the rates of RNFL thinning over the 6 × 6 mm2 RNFL thickness map and their application for indication of visual field (VF) worsening in patients with glaucoma.
OBJECTIVE: To investigate the association between the rates of RNFL thinning and the risk of VF worsening in patients with glaucoma. DESIGN, SETTING, AND PARTICIPANTS: This prospective study included 117 eyes of 89 Chinese patients with primary open-angle glaucoma followed up at approximate 4-month intervals for 5 or more years between July 1, 2007, and October 30, 2015, with progressive RNFL thinning detected by optical coherence tomography trend-based progression analysis (TPA). The mean and the peak rates of RNFL thinning and the area of progressive RNFL thinning were measured by the rates of change of RNFL thickness map. Visual field worsening was determined by the Early Manifest Glaucoma Trial and pointwise linear regression criteria. MAIN OUTCOMES AND MEASURES: Hazard ratios (HRs) for indication of VF worsening determined by time-varying Weibull survival models.
RESULTS: Of 89 patients (117 eyes) included in the study, 53 (59.6%) were men; mean (SD) age was 54.0 (13.8) years. At the time that progressive RNFL thinning was confirmed by TPA, the mean and the peak rates of RNFL thinning were 9.06 (8.05) µm/y and 4.52 (3.19) µm/y, respectively, and the area of progressive RNFL thinning was 1.54 (1.83) mm2. The inferotemporal meridians at 268° to 288° and the superotemporal meridians at 40° to 60° were the most frequent locations where progressive RNFL thinning was observed; 41.9% of the eyes had progressive RNFL thinning at these locations. After controlling for baseline covariates, the peak and the mean rates of RNFL thinning, but not the area of progressive RNFL thinning, were indicative of VF worsening. For each micrometer-per-year increase in the peak and the mean rates of RNFL thinning, the hazard ratios were 1.12 (95% CI, 1.04-1.19) for the peak rate and 1.39 (95% CI, 1.19-1.62) for the mean rate by the Early Manifest Glaucoma Trial criteria, and 1.07 (95% CI, 1.03-1.10) for the peak rate and 1.18 (95% CI, 1.09-1.28) for the mean rate by the pointwise linear regression criteria. CONCLUSIONS AND RELEVANCE: Topographic measurement of the rates of RNFL thinning by optical coherence tomography TPA is informative for risk assessment of VF loss in glaucoma. Although progressive RNFL thinning may not necessarily be associated with VF worsening, faster rates of RNFL thinning were associated with a higher risk of subsequent decline in VF.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28152147     DOI: 10.1001/jamaophthalmol.2016.5111

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  12 in total

Review 1.  Detecting Structural Progression in Glaucoma with Optical Coherence Tomography.

Authors:  Andrew J Tatham; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2017-12       Impact factor: 12.079

2.  Detecting Glaucomatous Progression With a Region-of-Interest Approach on Optical Coherence Tomography: A Signal-to-Noise Evaluation.

Authors:  Zhichao Wu; Abinaya Thenappan; Denis S D Weng; Robert Ritch; Donald C Hood
Journal:  Transl Vis Sci Technol       Date:  2018-02-28       Impact factor: 3.283

3.  Comparison of Widefield and Circumpapillary Circle Scans for Detecting Glaucomatous Neuroretinal Thinning on Optical Coherence Tomography.

Authors:  Zhichao Wu; Denis S D Weng; Abinaya Thenappan; Rashmi Rajshekhar; Robert Ritch; Donald C Hood
Journal:  Transl Vis Sci Technol       Date:  2018-06-04       Impact factor: 3.283

4.  Did the OCT Show Progression Since the Last Visit?

Authors:  Donald C Hood; Bruna Melchior; Emmanouil Tsamis; Jeffrey M Liebmann; Carlos G De Moraes
Journal:  J Glaucoma       Date:  2021-04-01       Impact factor: 2.290

Review 5.  Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma.

Authors:  Felipe A Medeiros
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-05-01       Impact factor: 4.799

6.  Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans.

Authors:  Zhichao Wu; Denis S D Weng; Rashmi Rajshekhar; Abinaya Thenappan; Robert Ritch; Donald C Hood
Journal:  Transl Vis Sci Technol       Date:  2018-05-01       Impact factor: 3.283

Review 7.  Annexins in Glaucoma.

Authors:  Timothy E Yap; Benjamin Michael Davis; Li Guo; Eduardo M Normando; Maria Francesca Cordeiro
Journal:  Int J Mol Sci       Date:  2018-04-17       Impact factor: 5.923

8.  An Artificial Intelligence Approach to Assess Spatial Patterns of Retinal Nerve Fiber Layer Thickness Maps in Glaucoma.

Authors:  Mengyu Wang; Lucy Q Shen; Louis R Pasquale; Hui Wang; Dian Li; Eun Young Choi; Siamak Yousefi; Peter J Bex; Tobias Elze
Journal:  Transl Vis Sci Technol       Date:  2020-08-27       Impact factor: 3.283

Review 9.  Discovery and clinical translation of novel glaucoma biomarkers.

Authors:  Gala Beykin; Anthony M Norcia; Vivek J Srinivasan; Alfredo Dubra; Jeffrey L Goldberg
Journal:  Prog Retin Eye Res       Date:  2020-07-10       Impact factor: 21.198

10.  Sample Size Requirements of Glaucoma Clinical Trials When Using Combined Optical Coherence Tomography and Visual Field Endpoints.

Authors:  Zhichao Wu; Felipe A Medeiros
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.